Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 144689-24-7 Chemical Structure| 144689-24-7

Structure of Olmesartan
CAS No.: 144689-24-7

Chemical Structure| 144689-24-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Olmesartan is an antagonist of angiotensin II receptor, working as an antihypertensive agent.

Synonyms: RNH-6270; CS 088; CS-866

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Olmesartan

CAS No. :144689-24-7
Formula : C24H26N6O3
M.W : 446.50
SMILES Code : O=C(O)C1=C(N=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4)CCC)C(O)(C)C
Synonyms :
RNH-6270; CS 088; CS-866
MDL No. :MFCD00914967
InChI Key :VTRAEEWXHOVJFV-UHFFFAOYSA-N
Pubchem ID :158781

Safety of Olmesartan

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Related Pathways of Olmesartan

GPCR

Isoform Comparison

Biological Activity

Target
  • AT1 receptor

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293-JumpIn-SLCO2A1 cells 100 µM 1 h To validate PGT-mediated PGE2 uptake, a leftward shift in the PGE2 concentration-response curve was observed, indicating that Olmesartan inhibited PGT-mediated PGE2 uptake. PMC11111933
Calu-3 cells 10 µM 24 h Olmesartan did not significantly affect ACE2 expression in Calu-3 cells PMC8503675
HUVECs 10 µM 24 h Olmesartan did not significantly affect ACE2 expression in HUVECs PMC8503675
HK-2 cells 5 ng/mL 16 h Olmesartan significantly reversed molecular alterations resulting from rhTGF β treatment in HK-2 cells, indicating its regulation of HK-2 cell fibrosis by targeting the RAS-TGF β feedback loop. PMC6695622
C2C12 cells 10^-5 mol/l 48 h To investigate the effect of Olmesartan on AngII-induced reduction in mitochondrial content, results showed that blockade of AT2R reversed the reduction in mitochondrial content, while blockade of AT1R had no such effect. PMC2646070

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Pregnancy-associated hypertensive (PAH) mouse model Oral 15 mg/L From day 13 to day 19 of pregnancy, daily administration Olmesartan restored the expression levels of Adra1a mRNA in the hearts of PAH mice by inhibiting the AT1 receptor. PMC10011504
Mice Anti-glomerular basement membrane antibody-induced glomerulonephritis model Oral 6 mg/kg Once daily until Day 7 To evaluate the therapeutic effects of Olmesartan on glomerular injury in Tg mice, results showed that Olmesartan significantly improved proteinuria and glomerular pathological changes in Tg mice. PMC3203629
nude mice bladder cancer xenograft model oral 10 mg/kg once daily for 14 days To evaluate the efficacy of ARB olmesartan in platinum-resistant bladder cancer xenograft models, the results showed that olmesartan significantly suppressed tumor growth PMC3241561
Mice KK-Ay mice (type 2 diabetes model) Oral 1 mg/kg Once daily for 56 days To evaluate the renoprotective effect of olmesartan combined with esaxerenone in type 2 diabetic mice. Results showed that the combination treatment significantly reduced the change in UACR and Ualb from baseline and inhibited the excretion of renal injury markers. PMC7685977
Mice Col4a3–/– mice Oral 5 mg/kg Once daily for 3 weeks Olmesartan effectively suppressed the progression of tubulointerstitial fibrosis in AS by interrupting the RAS-TGF β feedback loop, thereby counterbalancing intrarenal RAS activation and preserving ACE2 expression in tubular epithelial cells. PMC6695622
C57bl/6 mice AngII-induced diabetes model Oral 10 mg/kg Four times per week for 10 days To investigate the effect of Olmesartan on the AngII-induced diabetes model, results showed that Olmesartan partially reversed the AngII-induced reduction in mitochondrial content by blocking AT1R and improved glucose tolerance. PMC2646070

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01415466 Healthy Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System (Yuhs) Seoul, Korea, Republic of Less <<
NCT00185120 Hypertension Phase 4 Completed - United States, Alabama ... More >> Mobile, Alabama, United States, 36693 United States, California Memorial Research Medical Center Long Beach, California, United States, 90806 National Research Institute Los Angeles, California, United States, 90057 Clinical Trials Research Roseville, California, United States, 95661 Apex Research Institute Santa Ana, California, United States, 92705 Orange County Research Center Tustin, California, United States, 92780 Westlake Medical Center Westlake Village, California, United States, 91361 United States, Florida Clinical Research of South Florida Coral Gables, Florida, United States, 33134 The Greater Fort Lauderdale Heart Group Research Fort lauderdale, Florida, United States, 33308 SFBC International Miami, Florida, United States, 33142 CLIRECO, Inc. Tamarac, Florida, United States, 33321 United States, Indiana Midwest Institute for Clinical Research Indianapolis, Indiana, United States, 46260 United States, Kansas Heartland Research Associates Wichita, Kansas, United States, 67207 United States, Maine Androscoggin Cardiology Research Auburn, Maine, United States, 04210 United States, North Carolina Internal Medicine Associates of Charlotte Charlotte, North Carolina, United States, 28211 Piedmont Medical Research Associates Winston-salem, North Carolina, United States, 27103 United States, Ohio The Lindner Clinical Trial Center Cincinnati, Ohio, United States, 45319 United States, Rhode Island Omega Medical Research Warwick, Rhode Island, United States, 02886 United States, Tennessee Volunteer Research Group, University of Tennessee Med. Ctr. Knoxville,, Tennessee, United States, 37920 United States, Texas Punzi Medical Center Carrollton, Texas, United States, 75006 Less <<
NCT01028534 Obstructive Sleep Apnea ... More >> Hypertension Less << Not Applicable Completed - Japan ... More >> Kirigaoka Tsuda Hospital Kitakyushu, Japan Kyoto University Hospital Kyoto, Japan Less <<
NCT00523744 Hypertension Phase 3 Completed - Germany ... More >> Novartis Investigative Site, , Germany Schwerin, Germany Less <<
NCT01271374 Hypertension Phase 4 Unknown December 2011 United States, Georgia ... More >> Atlanta Clinical Research Center Tucker, Georgia, United States, 30084 Less <<
NCT01870739 Hypertension Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Erlangen, Germany, 91054 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Glasgow, Scotland, United Kingdom, G12 8TA Less <<
NCT00441350 Hypertension Phase 3 Completed - Israel ... More >> Tel-Aviv Sourasky Medical Center, Internal Medicine Ward D Tel-Aviv, Israel, 64239 Less <<
NCT01870739 - Completed - -
NCT00846365 Essential Hypertension Phase 3 Completed - -
NCT00134160 Hypertension ... More >>Cardiovascular Diseases Less << Phase 4 Completed - Japan ... More >> Department of Cardiovascular Medicine Graduate School of Medical Science Kumamoto University 1-1-1 Honjyo, Kumamoto-City, Kumamoto, Japan, 860-8556 OSCAR-Study Data Center ShinjukuParkTower30FN, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 163-1030 Less <<
NCT02089399 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT00523744 - Completed - -
NCT02609490 Hypertension Phase 3 Completed - China ... More >> Peking University First hospiatl Beijing, China, 100000 Less <<
NCT00171015 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00185068 Hypertension Phase 4 Completed - United States, California ... More >> Fort Lauderdale, California, United States Long Beach, California, United States Roseville, California, United States Sacramento, California, United States Santa Anna, California, United States Tustin, California, United States Westlake Village, California, United States United States, Florida Deland, Florida, United States Pembroke Pines, Florida, United States United States, Illinois Orland Park, Illinois, United States United States, Louisiana New Orleans, Louisiana, United States United States, Maine Auburn, Maine, United States United States, Nebraska Omaha, Nebraska, United States United States, New York Buffalo, New York, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, Wisconsin Madison, Wisconsin, United States Less <<
NCT02962258 Healthy Subjects Phase 1 Completed - -
NCT02665832 Healthy Phase 1 Unknown June 2016 -
NCT02962336 Healthy Subjects Phase 1 Completed - -
NCT00846365 - Completed - -
NCT00751829 Isolated Systolic Hypertension Phase 3 Completed - Germany ... More >> Munich, Germany Less <<
NCT01692301 - Completed - -
NCT01692301 Hypertension Phase 2 Completed - -
NCT00220233 Essential Hypertension Phase 3 Completed - Germany ... More >> Leipzig, Germany Sinsheim, Germany Tann, Germany Weinheim, Germany Wiesbaden, Germany Less <<
NCT01838850 Essential Hypertension Phase 3 Completed - Korea, Republic of ... More >> Korea University Ansan Hospital Ansan, Korea, Republic of, 425-707 Hallym University Medical Center Anyang, Korea, Republic of, 431-796 Soonchunhyang University Hospital Bucheon, Korea, Republic of, 420-767 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Pusan National University Hospital Busan, Korea, Republic of, 602-739 Daedong Hospital Busan, Korea, Republic of, 607-711 Inje University Haeundae Paik Hospital Busan, Korea, Republic of, 612-896 Inje University Busan Paik Hospital Busan, Korea, Republic of, 614-735 Chungbuk National University Hospital Cheongju, Korea, Republic of, 361-711, Presbyterian Medical Center Cheonju, Korea, Republic of, 560-750 Chonbuk National University Hospital Cheonju, Korea, Republic of, 561-712 Keimyung University Dongsan Medical Center Daegu, Korea, Republic of, 700-712 Daegu Catholic University Medical Center Daegu, Korea, Republic of, 705-718 Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Konyang University Hospital Daejeon, Korea, Republic of, 302-718 Health Insurance Service Ilsan Hospital Goyang, Korea, Republic of, 410-719 Hanyang University Guri Hospital Guri, Korea, Republic of, 471-701 Chonnam National University Hospital Gwangju, Korea, Republic of, 501-757 Gachon University Gil Medical Center Incheon, Korea, Republic of, 405-835 Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Severance Hospital Seoul, Korea, Republic of, 120-752 Kyung Hee University Medical Center Seoul, Korea, Republic of, 130-702 Kyunghee University Hospital at Gandong Seoul, Korea, Republic of, 134-727 Seoul Veterans Hospital Seoul, Korea, Republic of, 134-791 Sanmsung Medical Center Seoul, Korea, Republic of, 135-710 Gangnam Severance Hospital Seoul, Korea, Republic of, 135-720 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Seoul St. Mary's Hospital of the Catholic University of Korea Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Eulji General Hospital Seoul, Korea, Republic of, 139-711 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Yeouido St. Mary's Hospital of the Catholic University of Korea Seoul, Korea, Republic of, 150-713 Korea University Guro Hospital Seoul, Korea, Republic of, 152-840 Chung-Ang University Hospital Seoul, Korea, Republic of, 156-755 St. Carollo Hospital Suncheon, Korea, Republic of, 540-719 Ajou University Hospital Suwon, Korea, Republic of, 443-380 Ulsan University hospital Ulsan, Korea, Republic of, 682-714 Wonju Severance Christian Hospital Wonju, Korea, Republic of, 220-701 Less <<
NCT01823900 Healthy Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01493856 Healthy Volunteers Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System (Yuhs) Seoul, Korea, Republic of Less <<
NCT03560804 Arterial Stiffness ... More >> Ambulatory Blood Pressure Monitoring Less << Not Applicable Completed - Greece ... More >> Hypertension Excellence Center, AHEPA University Hospital Thessaloniki, Greece, 54635 Less <<
NCT01552954 Hypertension ... More >>Chronic Kidney Disease Microalbuminuria Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Kyeong ki, Korea, Republic of, 463787 Dongguk University Ilsan Hospital Ilsan, Kyeongki, Korea, Republic of, 410773 Seoul National University Hospital Seoul, Korea, Republic of, 110744 Kyung Hee University Seoul, Korea, Republic of, 134727 Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137701 Konkuk University School of Medicine Seoul, Korea, Republic of, 143729 SMG-SNU Boramae Medical Center Seoul, Korea, Republic of, 156707 Less <<
NCT00649389 Hypertension Phase 3 Completed - -
NCT00649389 - Completed - -
NCT00185133 Hypertension Phase 3 Completed - -
NCT00185055 Healthy Phase 4 Completed - -
NCT00220220 Essential Hypertension Phase 3 Completed - Germany ... More >> Hamburg, Germany Magdeburg, Germany Messkirch, Germany Stuhr, Germany Tann, Germany Worpswede, Germany Less <<
NCT01684748 Overweight Ob... More >>ese Prehypertension Hypertension Less << Phase 4 Completed - -
NCT01552954 - Completed - -
NCT00185094 Hypertension ... More >>Insulin Resistance Metabolic Syndrome Less << Phase 4 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, California San Diego, California, United States United States, Florida Miami, Florida, United States United States, Indiana Indianapolis, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Massachusetts Boston, Massachusetts, United States United States, Minnesota Rochester, Minnesota, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States Less <<
NCT01684748 - Completed - -
NCT00185159 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Disease Kidney Disease Less << Phase 3 Completed - Germany ... More >> Darmstadt, Germany Less <<
NCT00185185 Essential Hypertension ... More >> Atherosclerotic Cardiovascular Disease Less << Phase 3 Completed - Germany ... More >> Munich, Germany Less <<
NCT00696436 Hypertension Phase 3 Completed - -
NCT00412932 Hypertension Phase 4 Completed - -
NCT00679484 Chronic Heart Failure ... More >> High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level Less << Phase 3 Terminated(Lack of subject rec... More >>ruitment) Less << - France ... More >> Bron, France Cedex, France Cholet, France Langres, France Mannheim, France Pontoise, France Roubaix, France Germany Bad Nauheim, Germany Berlin, Germany Lambrecht, Germany Netherlands Ad Delft, Netherlands Less <<
NCT00098137 Heart Disease|Arrhythmia|Atria... More >>l Fibrillation Less << PHASE3 COMPLETED 2025-05-09 -
NCT00696436 - Completed - -
NCT00527514 Hypertension Phase 3 Completed - United States, California ... More >> Buena Park, California, United States Long Beach, California, United States Los Angeles, California, United States Sacramento, California, United States Tustin, California, United States Westlake Village, California, United States United States, Colorado Castle Rock, Colorado, United States United States, Florida Pembroke Pines, Florida, United States United States, Illinois Orland Park, Illinois, United States United States, Massachusetts Natick, Massachusetts, United States United States, New York New York, New York, United States United States, North Carolina Winston-Salem, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, Pennsylvania Beaver, Pennsylvania, United States United States, South Carolina Greer, South Carolina, United States United States, Texas Carrolton, Texas, United States Corpus Christi, Texas, United States United States, Wisconsin Madison, Wisconsin, United States Less <<
NCT00923091 Essential Hypertension Phase 3 Completed - -
NCT00382213 Atherosclerosis Phase 3 Completed - -
NCT00923091 - Completed - -
NCT00412932 - Completed - -
NCT00676845 Metabolic Syndrome ... More >> Hypertension Less << Phase 3 Completed - Belgium ... More >> Ghent, Belgium Germany Nurnberg, Germany Italy Monza, Italy Less <<
NCT00454662 Hypertension ... More >>Cardiovascular Disease Diabetes Less << Phase 4 Completed - Japan ... More >> COLM-Study Data Center Kamiyacho MT Bld.14F, 4-3-20 Toranomon Minato-ku, Tokyo, Japan, 105-0001 Less <<
NCT00527514 - Completed - -
NCT00141453 Diabetic Nephropathy ... More >> Type 2 Diabetes Mellitus Proteinuria Less << Phase 3 Completed - China ... More >> Hong Kong, China Japan Tokyo, Japan Less <<
NCT00772499 Hypertension Phase 4 Completed - United States, North Carolina ... More >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00607035 Hypertension Phase 4 Completed - Japan ... More >> Jichi Medical University School of Medicine Tochigi, Japan Less <<
NCT00654745 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Completed - United States, California ... More >> Los Angeles, California, United States Sylmar, California, United States Tustin, California, United States United States, Florida Aventura, Florida, United States DeLand, Florida, United States Hialeah, Florida, United States Pembroke Pines, Florida, United States United States, Indiana Avon, Indiana, United States Indianapolis, Indiana, United States United States, Nevada Las Vegas, Nevada, United States United States, New York New Windsor, New York, United States United States, North Carolina Winston-Salem, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, South Carolina Charleston, South Carolina, United States Greer, South Carolina, United States Taylors, South Carolina, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States United States, Virginia Burke, Virginia, United States Less <<
NCT03009487 Hypertension ... More >>Hyperlipidemias Less << Phase 3 Recruiting - Korea, Republic of ... More >> Seoul national university bundang hospital Recruiting Seoul, Korea, Republic of Contact: Wan Huh    +82-2-550-8106    whuh408@daewoong.co.kr Less <<
NCT00654745 - Completed - -
NCT00141453 - Completed - -
NCT01599104 - Completed - -
NCT00856271 Essential Hypertension Phase 3 Completed - China ... More >> Beijing, China Chongqing, China Guang Zhou, China Nanjing, China Shanghai, China Less <<
NCT01200407 - Terminated(The requirement for... More >> Post Marketing Surveillance was lifted by the Philippine FDA) Less << - -
NCT01599104 Essential Hypertension Phase 3 Completed - -
NCT00430508 Essential Hypertension Phase 3 Completed - -
NCT00362960 Type 2 Diabetes Mellitus ... More >> Diabetic Nephropathy Proteinuria Renal Disease Less << Phase 3 Completed - Czech Republic ... More >> Frydlant v Cechach, Czech Republic Liberec, Czech Republic Prague, Czech Republic Estonia Tartu, Estonia Germany Augsburg, Germany Greifenstein-Beilstein, Germany Hannover, Germany Netherlands Zwijndrecht, Netherlands Poland Grodzisk Mazowiecki, Poland Krakow, Poland Plock, Poland Poznan, Poland Pruszkow, Poland Torun, Poland Warsaw, Poland Watlack, Poland Wolomin, Poland Wroclaw, Poland Slovakia Banska Bystrica, Slovakia Kosice, Slovakia Lucenec, Slovakia Martin, Slovakia Nitra, Slovakia Nove Zamky, Slovakia Sahy, Slovakia Spain Barcelona, Spain Madrid, Spain Less <<
NCT00430508 - Completed - -
NCT01019590 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT01831479 Healthy Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT02516826 Coronary Syndrome Phase 2 Unknown August 2018 Korea, Republic of ... More >> Cardiac and Vascular Center; Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00902538 Essential Hypertension Phase 3 Completed - -
NCT00902538 - Completed - -
NCT00811226 - Completed - -
NCT01020214 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00751751 Essential Hypertension Phase 3 Completed - Germany ... More >> Darmstadt, Germany Less <<
NCT01033071 Essential Hypertension Phase 3 Completed - -
NCT00151827 Essential Hypertension ... More >> Renal Impairment Less << Phase 3 Completed - Germany ... More >> Darmstadt, Germany Less <<
NCT00648219 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT01033071 - Completed - -
NCT02483936 Arterial Hypertension Phase 3 Not yet recruiting September 2019 -
NCT03753477 Healthy Phase 1 Completed - Korea, Republic of ... More >> Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT00914524 Chronic Glomerulonephritis ... More >> Diabetic Nephropathy Less << Phase 2 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00857285 - Completed - -
NCT00857285 Essential Hypertension Phase 3 Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan Chung Shun Medical University Hospital Taichung City, Taiwan National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00403481 Hypertension Phase 4 Completed - -
NCT00417222 Chronic Heart Failure Phase 3 Completed - Japan ... More >> Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine Sendai-city, Japan, 980-8574 Less <<
NCT00858702 Hypertension Phase 4 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00858702 - Completed - -
NCT00854763 - Unknown - Taiwan ... More >> National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Kuo-Liong Chien, MD, PhD    +886-2-3366-8017    klchien@ntu.edu.tw    Principal Investigator: Kuo-Liong Chien, MD, PhD Less <<
NCT00139698 Essential Hypertension Phase 3 Completed - -
NCT00996281 Essential Hypertension Phase 3 Completed - Austria ... More >> Graz, Styria, Austria Germany Karlsruhe, Baden-Wurttemberg, Germany Hannover, Lower Saxony, Germany Kiel-Kronshagen, Schleswig-Holstein, Germany Netherlands Breda, North Brabant, Netherlands Eindhoven, North Brabant, Netherlands Amsterdam, North Holland, Netherlands Velp, Rheden, Netherlands Leiderdorp, South Holland, Netherlands Zoetermeer, South Holland, Netherlands Rotterdam, Zuid-Holland, Netherlands Groningen, Netherlands Poland Bydgoszcz, Kuyavian-Pomeranian, Poland Skierniewice, L0dz, Poland Zgierz, L0dz, Poland Gdansk, Pomeranian, Poland Gdynia, Pomeranian, Poland Sopot, Pomeranian, Poland Mikolow, Silesian, Poland United Kingdom Avon, England, United Kingdom Bolton, England, United Kingdom Chorley, England, United Kingdom Inverness, England, United Kingdom Liverpool, England, United Kingdom Surrey, England, United Kingdom Warwickshire, England, United Kingdom Less <<
NCT00872586 Essential Hypertension Phase 3 Completed - China ... More >> Beijing, China Chengdu, China Chongqing, China Guang Zhou, China Hang Zhou, China Nanjing, China Shanghai, China Wuhan, China Less <<
NCT00649623 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT03319706 Healthy Subjects Phase 1 Completed - -
NCT01309828 Safety Phase 3 Completed - -
NCT00949884 Hypertension Phase 4 Completed - United States, Arizona ... More >> Mesa, Arizona, United States, 85213 Phoenix, Arizona, United States, 85050 United States, California Harbor City, California, United States, 90710 Tustin, California, United States, 92780 Westlake Village, California, United States, 91361 United States, Colorado Pueblo, Colorado, United States, 81001 United States, Florida Deerfield Beach, Florida, United States, 33442 DeLand, Florida, United States, 32720 United States, Indiana South Bend, Indiana, United States, 46614 United States, Kansas Wichita, Kansas, United States, 67205 United States, Louisiana Metairie, Louisiana, United States, 70006 United States, New Mexico Albuquerque, New Mexico, United States, 87108 United States, New York Binghamton, New York, United States, 13701 United States, North Carolina Charlotte, North Carolina, United States, 28209 United States, Ohio Cincinnati, Ohio, United States, 45219 United States, South Carolina Greenville, South Carolina, United States, 29615 United States, Tennessee Bristol, Tennessee, United States, 37620 New Tazewell, Tennessee, United States, 37825 United States, Texas Dallas, Texas, United States, 75230 United States, Virginia Norfolk, Virginia, United States, 23502 Less <<
NCT00403481 - Completed - -
NCT03318354 Healthy Subjects Phase 1 Completed - -
NCT03655964 Stroke, Ischemic Phase 2 Recruiting December 20, 2018 Greece ... More >> AHEPA University Hospital Recruiting Thessaloniki, Greece, 54621 Contact: Vasileios Vaios, MD Less <<
NCT02373462 Peripheral Artery Disease With... More >> Intermittent Claudication Less << Phase 4 Unknown February 2018 Korea, Republic of ... More >> Division of Cardiology, Department of Internal Medicine, Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Dong-Hoon Choi, MD    82 2 2228 8449    cdhlyj@yuhs.ac Less <<
NCT00430638 Hypertension Phase 4 Completed - -
NCT00996281 - Completed - -
NCT00430950 - Completed - -
NCT00430638 - Completed - -
NCT01615198 Essential Hypertension Phase 3 Completed - -
NCT00430950 Essential Hypertension Phase 3 Completed - Belgium ... More >> Brugge, Belgium Brussels, Belgium Drongen, Belgium Godinne, Belgium Mouscron, Belgium Wetteren, Belgium Germany Berlin, Germany Dortmund, Germany Essen, Germany Frankfurt, Germany Goch, Germany Hamburg, Germany Kallstadt, Germany Karlsruhe, Germany Kassel, Germany Magdeburg, Germany Marburg, Germany Muenchen, Germany Wiesbaden, Germany Wuppertal, Germany Netherlands Alphen aan den Rijn, Netherlands Amsterdam Zuidoost, Netherlands Andijk, Netherlands De Bilt, Netherlands Den Bosch, Netherlands Den Haag, Netherlands Ewijk, Netherlands Heerlen, Netherlands Hengelo, Netherlands Landgraaf, Netherlands Nijmegen, Netherlands Oud-Beijerland, Netherlands Ridderkerk, Netherlands Wildervank, Netherlands Zwijndrecht, Netherlands Slovakia Bratislava, Slovakia Levice, Slovakia Lucenec, Slovakia Nitra, Slovakia Nove Zamky, Slovakia Vrable, Slovakia Less <<
NCT00949884 - Completed - -
NCT01615198 - Completed - -
NCT02493322 Essential Arterial Hypertensio... More >>n Less << Phase 3 Not yet recruiting November 2019 -
NCT00796159 - Completed - -
NCT00311155 Essential Hypertension Phase 4 Completed - -
NCT01309828 - Completed - -
NCT00311155 - Completed - -
NCT01876368 Hypertension Phase 3 Completed - -
NCT00890591 Essential Hypertension Phase 4 Completed - -
NCT01611077 Hypertension Phase 4 Completed - Germany ... More >> Praxis Dr. Reimer Anderbeck, Germany, 38836 Praxis Dr. Heinz Bergisch-Gladbach, Germany, 51429 Praxis Dr. Zemmrich Berlin, Germany, 12043 St.-Josefs-Hospital Cloppenburg, Germany, 49661 Praxis Dr. Pohl Dresden, Germany, 01129 Praxis Dr. Koßler-Wiesweg Essen, Germany, 45138 Praxis Dr. Rövenich Frankfurt, Germany, 65929 Praxis Dr. Strzata Kapellendorf, Germany, 99510 Praxis Dr. Paschmionka Leipzig, Germany, 04316 Praxis Dr. Pitule Ludwigshafen, Germany, 67061 Praxis Dr. Loddo Rastede, Germany, 26180 Less <<
NCT00151775 Hypertension Phase 2 Phase 3 Completed - -
NCT00891267 Metabolic Syndrome ... More >> Hypertension Less << Phase 3 Completed - Germany ... More >> Erlangen, Germany Less <<
NCT01876368 - Completed - -
NCT00151775 - Completed - -
NCT00890591 - Completed - -
NCT00185172 Essential Hypertension Phase 3 Completed - Austria ... More >> Result Cro Wien, Austria, 1130 Germany INPUT GmbG Aachen, Germany, 52074 Italy Biokos Farma s.r.l. Bologna, Italy, 40122 Netherlands IMRO TRAMARKO International bv Berghem, Netherlands, 5352 Portugal EUROTRIALS Lda Lisboa, Portugal, 1070-274 Spain Phidea S.L. Madrid, Spain, 28002 Switzerland PFC Pharma Focus Consultants AG Zurich, Volketswil, Switzerland, 8604 United Kingdom Inveresk Ltd. Edinburgh, United Kingdom Less <<
NCT01613209 Hypertension Phase 3 Completed - Germany ... More >> Praxis Dr. Loddo Rastede, Niedersachsen, Germany, 26180 Praxis Dr. Paschmionka Leipzig, Sachsen, Germany, 04316 Praxis Dr. Reimer Anderbeck, Germany, 38836 Praxis Dr. Heinz Bergisch-Gladbach, Germany, 51429 Praxis Dr. Zemmrich Berlin, Germany, 12043 Praxis Dr. Biedermann Blankenhain, Germany, 99444 St.-Josefs-Hospital Cloppenburg, Germany, 49661 Praxis Dr. Pohl Dresden, Germany, 01129 Praxis Koßler-Wiesweg Essen, Germany, 45138 Praxis Dr. Rövenich Frankfurt, Germany, 65929 Praxis Dr. Strzata Kapellendorf, Germany, 99510 Praxis Dr. Pitule Ludwigshafen, Germany, 67061 Less <<
NCT02407210 Essential Hypertension Phase 3 Unknown - China ... More >> Beijing ANZHEN Hospital Recruiting Beijing, China, 100029 Contact: Changsheng Ma, Professor    86-010-64456078    chshma@vip.sina.com    Principal Investigator: Changsheng Ma, Professor Less <<
NCT00151814 Hypertension Phase 1 Completed - United States, Arkansas ... More >> Little Rock, Arkansas, United States United States, California La Jolla, California, United States United States, Kentucky Louisville, Kentucky, United States United States, Missouri Kansas City, Missouri, United States United States, Ohio Cleveland, Ohio, United States Less <<
NCT00151814 - Completed - -
NCT01785472 Essential Hypertension Phase 3 Completed - -
NCT01785472 - Completed - -
NCT02848170 Essential Hypertension Not Applicable Completed - Japan ... More >> Tokyo, Japan Less <<
NCT02360956 Coronary Atherosclerosis Phase 4 Unknown June 2016 China ... More >> Chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Chen Yundai    86-10-55499246    cyundai301@126.com Less <<
NCT01907373 Drug Interaction of Olmesartan... More >> in Healthy Chinese Volunteers Less << Phase 4 Completed - China, Hunan ... More >> Center of New Drug Clinical Trial, Hunan Provincial Tumor Hospital (The Affiliated Tumor Hospital of Xiangya Medical School of Central South University) Changsha, Hunan, China, 410006 Less <<
NCT02996916 Efficacy of Olmesartan on Cere... More >>bral Glucose Metabolism in Essential Hypertension Less << Phase 4 Recruiting December 2020 Japan ... More >> Kurume University Hospital Recruiting Kurume, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp    Contact: Akihiro Honda, MD, PhD    +81-942-31-7580    honda_akihiro@med.kurume-u.ac.jp Less <<
NCT01132768 Essential Hypertension ... More >> Carotid Plaque Less << Phase 4 Terminated(Low recruitment) - Italy ... More >> Sesto Fiorentino, Italy, 50019 Less <<
NCT05189015 Angiotensin/Renin/Aldosterone ... More >>Hypertension|Hypertension|Diabetes Mellitus, Type 2 Less << PHASE4 COMPLETED 2023-06-30 Seoul National University Bund... More >>ang Hospital, Seongnam, Gyeonggi, 463-707, Korea, Republic of Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.20mL

2.24mL

1.12mL

22.40mL

4.48mL

2.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories